Approved indications
Oral tacrolimus immediate-release (e.g., Prograf) is approved to prevent organ rejection in kidney, liver, and heart transplant recipients, including adults and certain pediatric patients; extended-release products (e.g., Astagraf XL, Envarsus XR) are approved mainly for kidney transplant rejection prophylaxis in adults (and for some products, in pediatric kidney transplant patients).

Off-label uses and evidence
Clinicians may use oral tacrolimus off-label for conditions such as graft-versus-host disease after stem cell transplant, certain difficult-to-treat autoimmune or kidney diseases (for example, some forms of glomerulonephritis or nephrotic syndrome), and other immune-mediated disorders, generally supported by small trials, observational studies, or specialty guidelines rather than large pivotal FDA registration trials.

Efficacy expectations
After solid-organ transplantation, tacrolimus is a cornerstone immunosuppressant and substantially lowers the risk of acute rejection when used with other agents such as corticosteroids and antiproliferative drugs; many patients maintain good long-term graft function when levels are kept in the target range and other risk factors are controlled.

Benefits begin as soon as therapeutic blood levels are achieved (within days of starting therapy), though long-term success depends on adherence and careful dose adjustment.

Compared with some older agents like cyclosporine, tacrolimus generally provides at least similar or better rejection prevention in many transplant settings, but it carries a notable risk of kidney toxicity, neurologic effects, and metabolic problems that must be balanced against its efficacy.

Typical dosing and how to take
Dosing is highly individualized based on the type of transplant, time since transplantation, other immunosuppressants, and blood tacrolimus levels, but initial total daily doses often fall in the range of about 0.1–0.2 mg/kg/day for immediate-release capsules (split into two doses taken about 12 hours apart) and somewhat lower total daily doses for extended-release tablets or capsules taken once daily.

Take tacrolimus at the same times every day, either consistently with food or consistently without food as directed, because food (especially high-fat meals) can affect absorption; swallow extended-release products whole without crushing or chewing.

Special dosing instructions
Your transplant team will regularly measure tacrolimus trough levels (usually just before the next dose) and may change the dose many times, especially early after transplant, to balance rejection prevention with side effects.

Do not switch between immediate-release and extended-release products, or between different manufacturers, without explicit instructions and new level checks, because the formulations are not directly interchangeable.

Missed-dose guidance
If you miss a dose and it is only been a short time, take it as soon as you remember; if it is almost time for your next dose, skip the missed dose and resume your regular schedule—do not double up to make up for a missed dose.

If you miss more than one dose, contact your transplant team promptly, as missing doses can increase the risk of rejection.

Overdose
In suspected overdose (taking more than prescribed or a child ingesting the medicine), seek emergency medical care or contact a poison control center right away, and bring the medication container so clinicians know exactly what was taken.

Common side effects
Frequent effects include tremor, headache, trouble sleeping, nausea, diarrhea, abdominal discomfort, high blood pressure, and increased blood sugar or cholesterol; many appear in the first days to weeks of therapy and may lessen as the dose is adjusted.

Patients may also notice increased risk of infections (such as colds, urinary infections), tingling or numbness, and swelling or weight gain; these are usually mild to moderate but should be reported if persistent or worsening.

Serious or rare adverse effects
Serious problems that need immediate medical attention include signs of kidney injury (reduced urine, swelling, sudden weight gain), severe or sudden headache, confusion, seizures, vision changes, chest pain, rapid or irregular heartbeat, shortness of breath, or severe abdominal pain.

Tacrolimus increases the risk of serious infections and certain cancers (especially lymphomas and skin cancers); unusual lumps, night sweats, fevers, or new or changing skin lesions should be evaluated promptly.

Rare but important reactions include posterior reversible encephalopathy syndrome (PRES), dangerously high potassium levels, and severe allergic reactions with rash, swelling of the face or throat, or difficulty breathing.

Warnings and precautions
Tacrolimus can harm kidney function and may worsen existing kidney or liver disease; such patients require lower doses and close monitoring.

It can raise blood pressure and blood sugar and may precipitate or worsen diabetes, so people with hypertension, diabetes, or cardiovascular disease need extra monitoring and management.

During pregnancy, tacrolimus is used when the benefit (such as preventing organ rejection) clearly outweighs risks; it can cross the placenta and is associated with prematurity and low birth weight, so specialist care and close monitoring of both parent and fetus are essential.

Tacrolimus passes into breast milk in small amounts; many transplant and pediatric specialists may allow breastfeeding with careful infant monitoring, but the decision should be individualized with the care team.

Relative safety compared with other drugs
Compared with other calcineurin inhibitors, tacrolimus has similar overall safety concerns, with a tendency toward more neurotoxicity and diabetes but often less cosmetic effects (such as gum overgrowth or excessive hair growth) than cyclosporine.

Its narrow therapeutic index means that small changes in dose, other drugs, or diet can significantly change blood levels, so monitoring and consistent dosing habits are critical to reduce toxicity.

Side-effect reporting and safety updates
Patients in the United States can report suspected side effects to the FDA MedWatch program (online or by phone) and should review the current Medication Guide and labeling, which are periodically updated as new safety information becomes available.

Major drug and food interactions
Tacrolimus is broken down mainly by CYP3A enzymes, so many drugs that affect these enzymes can raise or lower tacrolimus levels.

Common medicines that can increase tacrolimus levels (and risk of toxicity) include certain antifungals (such as ketoconazole, itraconazole, voriconazole), some antibiotics (clarithromycin, erythromycin), HIV or hepatitis C protease inhibitors, and some heart and blood pressure medicines (diltiazem, verapamil, amiodarone).

Medicines that may decrease tacrolimus levels (and increase rejection risk) include rifampin, rifabutin, carbamazepine, phenytoin, phenobarbital, some anti-HIV medications, and the herbal supplement St. John’s wort.

Grapefruit and grapefruit juice can significantly increase tacrolimus levels and should generally be avoided; large amounts of alcohol may worsen dizziness, liver stress, or other side effects and should be limited or avoided per your transplant team’s advice.

Other interaction considerations
Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and other nephrotoxic drugs, can add to kidney toxicity risk when combined with tacrolimus.

Live vaccines (such as certain forms of measles, mumps, rubella, varicella, and some intranasal flu vaccines) should generally be avoided while taking tacrolimus due to suppressed immunity; discuss all vaccines with your transplant team.

Precautions and conditions needing caution
Use with extra caution in people with kidney disease, liver impairment, uncontrolled high blood pressure, heart rhythm problems, or a history of neurologic disorders like seizures or stroke.

People with diabetes or at high risk for diabetes need close monitoring because tacrolimus can increase blood sugar; dose adjustments or additional diabetes medications may be needed.

Monitoring needs
Regular blood tests are essential, including tacrolimus trough levels, kidney and liver function tests, electrolytes (especially potassium and magnesium), blood sugar, cholesterol, and blood counts.

Blood pressure and weight should be monitored frequently, and depending on your risk factors, your team may occasionally check heart rhythm (ECG) or other specialized tests.

Q: What is tacrolimus used for?
A: Tacrolimus is mainly used after organ transplantation (such as kidney, liver, or heart) to prevent your immune system from rejecting the new organ.

Q: How long will I need to take tacrolimus?
A: Most transplant recipients need tacrolimus or another immunosuppressant for as long as the transplanted organ is functioning, often for life, although doses may be adjusted over time.

Q: Do I need regular blood tests while on tacrolimus?
A: Yes, you will need frequent blood tests, especially early on, to measure tacrolimus levels and to check kidney function, electrolytes, blood counts, and blood sugar so the dose can be kept safe and effective.

Q: Can I drink grapefruit juice or take herbal supplements with tacrolimus?
A: Grapefruit products and certain herbal supplements (especially St. John’s wort) can greatly change tacrolimus levels and should not be used unless specifically cleared by your transplant team.

Q: What should I do if I feel sick or get a fever while taking tacrolimus?
A: Because tacrolimus weakens your immune system, you should contact your transplant or healthcare team promptly if you develop fever, chills, a new cough, burning with urination, or other signs of infection.

Q: Is tacrolimus safe during pregnancy or breastfeeding?
A: Tacrolimus can be used in pregnancy and sometimes during breastfeeding when necessary to protect the transplanted organ, but it requires individualized risk–benefit discussion and close monitoring of both parent and baby.

Storage
Store capsules or tablets at room temperature (about 68°F to 77°F / 20°C to 25°C), away from excess heat and moisture, in the original tightly closed container.

Keep out of reach of children and pets and protect from light and humidity (do not store in the bathroom).

Disposal
Use a pharmacy or community drug take-back program when possible; if unavailable, mix unused capsules or tablets (do not crush extended-release tablets) with an unappealing substance (such as used coffee grounds or cat litter), seal in a bag or container, and place in household trash.